Prothipendyl

This classification denotes an antipsychotic agent with the molecular formula C16H19N3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5O6VWA87VA, chemically known as 10h-pyrido(3,2-b)(1,4)benzothiazine-10-propanamine, n,n-dimethyl- but generally known as prothipendyl, which bears US NIH Compound Identifier 14670. European Medicines Agency schedules Prothipendyl in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10138MIG. The term PROTHIPENDYL is an International Non-Proprietary Name. World Health Organization schedules prothipendyl in its Anatomical Therapeutic Chemical (ATC) Classification. PROTHIPENDYL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule prothipendyl under HS 29349990 and SITC 51579. As of Q4 2014, PROTHIPENDYL remains the US FDA Preferred Term for this commodity. Prothipendyl bears US NLM identifiers UMLS ID C0139007 and NCI Concept Code C84124. SMILES: S1C2C(N(CCCN(C)C)C3NCCCC13)CCCC2.